Shinva Medical Instrument Co.,Ltd. (SHA:600587)
China · Delayed Price · Currency is CNY 12.18
-0.27 (-2.17%)
Nov 13, 2026, 3:00 PM CST
Shinva Medical Instrument Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 10,113 | 9,736 | 10,021 | 10,012 | 9,282 | 9,482 |
Revenue Growth | 5.62% | -2.84% | 0.09% | 7.87% | -2.11% | 3.62% |
Gross Profit Gross Profit Growth | 2,418 | 2,372 | 2,559 | 2,618 | 2,419 | 2,282 |
Operating Income Operating Income Growth | 609.1 | 580.21 | 741.93 | 670.31 | 572.27 | 567.33 |
Net Income Net Income Growth | 452.76 | 526.34 | 691.61 | 654 | 500.07 | 556.49 |
Earnings Per Share EPS Growth | 0.75 | 0.87 | 1.14 | 1.09 | 0.95 | 1.05 |
EPS Growth | -2.18% | -23.68% | 4.59% | 15.20% | -10.21% | 136.17% |
Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Medical Device Manufacturing Products Medical Device Manufacturing Products Growth | 3,695 |
Medical Services Medical Services Growth | 678.17 |
Medical Trade Products Medical Trade Products Growth | 2,911 |
Pharmaceutical Equipment Products Pharmaceutical Equipment Products Growth | 2,187 |
Total Total Growth | 9,471 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 3,015 | 3,095 | 2,946 | 3,288 | 1,789 | 1,675 |
Total Debt Total Debt Growth | 1,081 | 1,187 | 1,136 | 1,099 | 1,193 | 1,186 |
Net Cash (Debt) Net Cash Growth | 1,933 | 1,908 | 1,810 | 2,189 | 596.64 | 488.82 |
Net Cash Growth | 19.92% | 5.44% | -17.34% | 266.96% | 22.06% | - |
Net Cash Per Share Net Cash Per Share Growth | 3.20 | 3.15 | 2.98 | 3.65 | 1.13 | 0.93 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 707.92 | 700.64 | 450.73 | 1,030 | 388.05 | 1,403 |
Capital Expenditures CapEx Growth | -149.7 | -381.55 | -420.88 | -535.77 | -247.58 | -274.36 |
Free Cash Flow Free Cash Flow Growth | 558.21 | 319.09 | 29.85 | 494.34 | 140.47 | 1,128 |
Free Cash Flow Growth | 113.00% | 969.00% | -93.96% | 251.91% | -87.55% | 24.42% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 23.91% | 24.36% | 25.54% | 26.15% | 26.06% | 24.06% |
Operating Margin | 6.02% | 5.96% | 7.40% | 6.69% | 6.17% | 5.98% |
Pretax Margin | 5.05% | 6.07% | 7.94% | 7.38% | 6.21% | 7.57% |
Profit Margin | 4.48% | 5.41% | 6.90% | 6.53% | 5.39% | 5.87% |
FCF Margin | 5.52% | 3.28% | 0.30% | 4.94% | 1.51% | 11.90% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.200 | 0.350 | 0.250 | 0.385 | 0.115 | 0.115 |
Dividend Per Share Growth | 40.00% | 40.00% | -35.00% | 233.28% | 0% | 50.07% |
Dividend Yield | 1.64% | 2.43% | 1.50% | 1.94% | 0.70% | 0.47% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.24 | 16.60 | 14.61 | 18.40 | 17.65 | 23.52 |
Forward PE | - | 10.67 | 11.25 | 14.33 | 15.79 | 20.64 |
P/FCF Ratio | 13.24 | 27.38 | 338.41 | 24.35 | 62.82 | 11.60 |
PS Ratio | 0.73 | 0.90 | 1.01 | 1.20 | 0.95 | 1.38 |